Search
Technicians create prosthetics using cutting-edge CAD/CAM system Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – A lab at the UT Health San Antonio School of Dentistry is using leading computer-aided automation that includes a partnership with a major international digital prosthetics company to test cutting-edge milling equipment for making crowns and other dental…
The San Antonio Business Journal recently released its list of honorees for the 2022 Women’s Leadership Awards, recognizing Andrea Marks, MBA, CPA, senior executive vice president and chief operating officer, as an outstanding leader in the community.
In response to the growing need for mental health resources and assistance in our community, the UT Police Department is pleased to announce the formation of a Mental Health Unit.
Deaths nearly 40% higher than for white women, pegged to lower access to care Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – Black women die of breast cancer at rates nearly 40% higher than white women, despite having lower instances of the disease, because of racial disparities in care, according to a New England Journal […]
In a special section of the June 17, 2022, San Antonio Business Journal, experts from Mays Cancer Center at UT Health San Antonio discuss the broad scope of cancer patient care and lifesaving research taking place daily at the center and its value to the local community and regional economy.
An experimental brain injury medication conceived in laboratories at UT Health San Antonio was tested Tuesday, June 14, in the first human subject. If the drug, called AST-004, performs well in human studies, it will be an urgently needed and novel treatment for stroke and traumatic brain injury victims, including those with concussions.
Drs. Ruben Mesa, Kate Lathrop and Mark Bonnen of the Mays Cancer Center took part in a panel discussion for this story. Read More
Dr. James Lechleiter, Cell Systems and Anatomy, is featured in this story. Read More
Dr. Mandie Svatek, Pediatrics, was interviewed for this story. Read More
James D. Lechleiter, PhD, professor of cell systems and anatomy at UT Health San Antonio, and Andrea Giuffrida, PhD, vice president for strategic industry ventures at UT Health San Antonio, were quoted in this story about the first human test of experimental brain injury medication conceived in laboratories at UT Health San Antonio. Read More